Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Interleukin-6 induces cellular insulin resistance in hepatocytes.

Senn JJ, Klover PJ, Nowak IA, Mooney RA.

Diabetes. 2002 Dec;51(12):3391-9.

2.

Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes.

Senn JJ, Klover PJ, Nowak IA, Zimmers TA, Koniaris LG, Furlanetto RW, Mooney RA.

J Biol Chem. 2003 Apr 18;278(16):13740-6.

3.

Modified Si-Miao-San extract inhibits inflammatory response and modulates insulin sensitivity in hepatocytes through an IKK╬▓/IRS-1/Akt-dependent pathway.

Liu K, Luo T, Zhang Z, Wang T, Kou J, Liu B, Huang F.

J Ethnopharmacol. 2011 Jul 14;136(3):473-9. doi: 10.1016/j.jep.2011.01.051.

PMID:
21296137
4.

Growth hormone induces cellular insulin resistance by uncoupling phosphatidylinositol 3-kinase and its downstream signals in 3T3-L1 adipocytes.

Takano A, Haruta T, Iwata M, Usui I, Uno T, Kawahara J, Ueno E, Sasaoka T, Kobayashi M.

Diabetes. 2001 Aug;50(8):1891-900.

5.

Interleukin-1alpha inhibits insulin signaling with phosphorylating insulin receptor substrate-1 on serine residues in 3T3-L1 adipocytes.

He J, Usui I, Ishizuka K, Kanatani Y, Hiratani K, Iwata M, Bukhari A, Haruta T, Sasaoka T, Kobayashi M.

Mol Endocrinol. 2006 Jan;20(1):114-24.

PMID:
16150868
6.
7.

Infusion of beta-endorphin improves insulin resistance in fructose-fed rats.

Su CF, Chang YY, Pai HH, Liu IM, Lo CY, Cheng JT.

Horm Metab Res. 2004 Aug;36(8):571-7.

PMID:
15326568
8.

IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells.

Ahmad F, Gao G, Wang LM, Landstrom TR, Degerman E, Pierce JH, Manganiello VC.

J Immunol. 1999 Apr 15;162(8):4864-75.

10.

Insulin receptor substrate-2-dependent interleukin-4 signaling in macrophages is impaired in two models of type 2 diabetes mellitus.

Hartman ME, O'Connor JC, Godbout JP, Minor KD, Mazzocco VR, Freund GG.

J Biol Chem. 2004 Jul 2;279(27):28045-50.

11.
12.
13.

Muscle damage impairs insulin stimulation of IRS-1, PI 3-kinase, and Akt-kinase in human skeletal muscle.

Del Aguila LF, Krishnan RK, Ulbrecht JS, Farrell PA, Correll PH, Lang CH, Zierath JR, Kirwan JP.

Am J Physiol Endocrinol Metab. 2000 Jul;279(1):E206-12.

14.
15.

Interferon-dependent activation of the serine kinase PI 3'-kinase requires engagement of the IRS pathway but not the Stat pathway.

Uddin S, Majchrzak B, Wang PC, Modi S, Khan MK, Fish EN, Platanias LC.

Biochem Biophys Res Commun. 2000 Apr 2;270(1):158-62.

PMID:
10733921
16.

Protein-tyrosine phosphatase-1B negatively regulates insulin signaling in l6 myocytes and Fao hepatoma cells.

Egawa K, Maegawa H, Shimizu S, Morino K, Nishio Y, Bryer-Ash M, Cheung AT, Kolls JK, Kikkawa R, Kashiwagi A.

J Biol Chem. 2001 Mar 30;276(13):10207-11.

18.

IRS-1 tyrosine phosphorylation reflects insulin-induced metabolic and mitogenic responses in 3T3-L1 pre-adipocytes.

Telting D, van der Zon GC, Dorrestijn J, Maassen JA.

Arch Physiol Biochem. 2001 Feb;109(1):52-62.

PMID:
11471071
19.
20.

Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle.

Dokken BB, Sloniger JA, Henriksen EJ.

Am J Physiol Endocrinol Metab. 2005 Jun;288(6):E1188-94.

Supplemental Content

Support Center